Publication | Open Access

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

Rheumatoid DisorderRheumatologyAutoimmune DiseaseSpondyloarthritisOsteoarthritisInflammatory Rheumatic DiseaseSclerodermaMedicineOrthopaedic SurgeryRheumatoid Arthritis